Current Landscape of Targeted Therapy in Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current Landscape of Targeted Therapy in Lung Cancer

Published:2017-09-25 Issue:5 Volume:102 Page:757-764
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Mayekar Manasi K.¹²³,Bivona Trever G.¹²³

Affiliation:

1. Department of Medicine; University of California; San Francisco San Francisco USA

2. Department of Cellular and Molecular Pharmacology; University of California; San Francisco San Francisco USA

3. Helen Diller Family Comprehensive Cancer Center; University of California; San Francisco San Francisco USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.810/fullpdf

Reference75 articles.

1. N. Comprehensive molecular profiling of lung adenocarcinoma;Cancer Genome Atlas Research;Nature,2014

2. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas;Campbell;Nat. Genet.,2016

3. The ErbB/HER family of protein-tyrosine kinases and cancer;Roskoski;Pharmacol. Res.,2014

4. FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets;Cohen;Oncologist,2003

5. FDA drug approval summary: erlotinib (Tarceva) tablets;Cohen;Oncologist,2005

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced non-squamous NSCLC with no actionable oncogenic driver in Spain: a cross-sectional descriptive analysis of data from the Thoracic Tumor Registry;Clinical and Translational Oncology;2024-06-11

2. Metformin and buparlisib synergistically induce apoptosis of non-small lung cancer (NSCLC) cells via Akt/FoxO3a/Puma axis;Toxicology in Vitro;2024-05

3. Three-in-one erlotinib-modified NIR photosensitizer for fluorescence imaging and synergistic chemo-photodynamic therapy;Chinese Chemical Letters;2024-04

4. Clinico-morphological characteristics of SMARCA4-deficient lung cancer;Clinical Case in Oncology;2024-03-25

5. Histology profiling of lung tumors: tru-cut versus full-core system for CT-guided biopsies;La radiologia medica;2024-03-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3